Simultaneous determination of rufloxacin, fenbufen and felbinac in human plasma using high-performance liquid chromatography

Add time:07/23/2019    Source:sciencedirect.com

A simple, specific and sensitive high-performance liquid chromatographic method has been developed for the simultaneous determination of rufloxacin, fenbufen and felbinac in human plasma. Plasma, spiked with internal standard, was vortex-mixed for 1 min with a mixture of dichloromethane-diethyl ether (80:20, v/v). The evaporated extract was dissolved in 0.02 M NaOH. Drugs were resolved at room temperature on a 5 μm Zorbax SAX column (250×4.6 min I.D.) equipped with a 20×4.6 mm anion-exchange Vydac AXGU ( 10 μm particle size) precolumn. The mobile phase consisted of acetonitrile and phosphate buffer (pH 7.0), delivered at a flow-rate of 1.2 ml/min. Detection was made at 280 nm, 2-[4-(2′-Furoyl)phenyl]propionic acid was used as internal standard. The calibration curve was linear from 0.2 to 10μg/ml for rufloxacin, from 0.5 to 30 μg/ml for fenbufen and from 0.2 to 10 μg/ml for felbinac, respectively. The detection limit was 0.1 μg/ml for rufloxacin. 0.3 μg/ml for fenbufen and 0.1 μg/ml for felbinac, respectively.

We also recommend Trading Suppliers and Manufacturers of Rufloxacin hydrochloride (cas 106017-08-7). Pls Click Website Link as below: cas 106017-08-7 suppliers

Prev:Photosensitization induced by the antibacterial fluoroquinolone Rufloxacin leads to mutagenesis in yeast
Next:Fluorimetric assay of rufloxacin in serum and in pharmaceutical formulations)